Mini-reviewMicroRNAs as modulators of T cell functions in cancer
Introduction
T lymphocytes are central players in cell-mediated immunity, and they can be classified into two major subsets: CD4+ T helper (TH) lymphocytes modulate the quality and magnitude of immune responses through the release of cytokines, secreted proteins able to influence cellular functions related to antimicrobial responses; CD8+ T cytotoxic lymphocytes are instead endowed with the ability to directly recognize and kill infected or transformed cells [1]. Despite the central role of T lymphocytes in protecting our organism from invading pathogens, their activity must be carefully regulated to avoid excessive tissue damage, altered inflammatory and anti-tumoral responses or even oncogenic transformation. At a molecular level, T cell proliferation and functions are therefore regulated by a complex network of transcriptional and post-transcriptional mechanisms that integrate extracellular cues to finally provide responses appropriately tailored against each invading pathogen or noxious agent. Such regulatory mechanisms include transcription factors, epigenetic modifications, signaling molecules and also microRNAs (miRNAs).
MiRNAs are short (∼21–23 nucleotides) non-coding RNAs that act post-transcriptionally by targeting primarily the 3′ untranslated regions (3′ UTRs) of cellular mRNA transcripts, in order to negatively regulate their expression [2]. The mature miRNAs derive from longer primary transcripts that undergo multiple steps of processing, mediated by the RNase III enzymes Drosha and Dicer [3]. Due to their short length and to the fact that they recognize their target mRNAs through imperfect base pairing [4], each miRNA can potentially affect multiple mRNAs, and consequently influence several downstream cellular pathways. The general importance of miRNAs in T cell biology is revealed by the many instances in which they were shown to have key roles in regulating lymphocyte development, differentiation and functions. For example, genetic ablation of the core enzymes crucial for miRNA biogenesis and maturation, namely Drosha and Dicer, caused reduced number and survival of T cells in vivo due to global impairment of miRNA expression, underlining the essential role of miRNAs in T cell development [[5], [6], [7]]. Specifically, deletion of Dicer early in T cell development impaired the survival of T cells expressing the αβ subunits of the T cell receptor (TCR), while γδ-expressing cells were not compromised [7]. Deletion of Dicer at later stages of differentiation led to a severe reduction in the development of CD8+ cytotoxic T cells, and to a reduced number and altered polarization of CD4+ TH lymphocytes [5]. Global impairment of miRNA processing in differentiated, mature TH cells affected cell proliferation and effector functions, as shown by the fact that cells lacking Dicer, Drosha or DGCR8 (a binding partner of Drosha) exhibited similar defects, namely increased expression of the cytokine interferon (IFN)-γ and reduced proliferation rate, pointing towards a key role for miRNAs in modulating T cell polarization and responses [6,8]. While T cell biology is clearly affected by the overall impairment of miRNA expression, individual miRNAs are also able to influence functionality and pathogenicity of T lymphocytes, as discussed below.
As for a role of miRNAs in disease, evidences from miRNA profiling experiments suggest that pathological conditions like lymphomas, hematological cancers and autoimmune diseases are also influenced by mutations or dysregulated expression of miRNAs [9]. Indeed, about half of the human miRNA genes can be found at fragile sites of the chromosomes, which are regions susceptible to modifications involved in malignant cell transformation [10]. Moreover, a systematic analysis of miRNA expression in more than 300 human samples was able to classify multiple tumor types based on miRNA expression levels, which were found to be generally downregulated compared to normal tissues. This analysis also provided more accurate information about developmental lineage and differentiation state of the tumor types with respect to classic mRNA profiling [11].
Here, we will discuss how miRNA expression in T lymphocytes can directly and indirectly affect oncogenic transformation, and we will focus primarily on three extensively studied miRNAs known to influence many aspects of T cell biology, namely miR-155, miR-146a and miR-181a. These miRNAs modulate proliferation, activation, inflammation and immune surveillance, with opposing roles in enhancing (oncomiRs) or restricting (oncosuppressor miRNAs) oncogenic transformation, representing therefore a general example of how miRNAs can affect T cell function in cancer. Indeed, dysregulated expression of these miRNAs was linked to different neoplastic diseases, and their ablation or overexpression was shown to be functionally relevant for cancer development [[12], [13], [14]]. In light of the current data, we will comment on how these miRNAs can affect both malignant transformation of T lymphocytes and immune surveillance (Fig. 1). While we will mainly focus on miR-155, miR-146a and miR-181a as examples, many other miRNAs (e.g. the miR-17~92 cluster and the miR-29 family) have been thoroughly studied in the context of lymphocyte responses or cancer development, and we refer the reader to more comprehensive recent reviews on the topic [[15], [16], [17]].
Section snippets
Regulation of T cell functions
Upon activation, TH lymphocytes differentiate into a variety of effector and regulatory subsets, characterized by the expression of specific cytokines and transcription factors. For example, TH1 lymphocytes express the transcription factor T-BET and produce IFN-γ, while TH2 cells express GATA-3 and produce primarily interleukin (IL)-4 [18]. A further subset of regulatory T (Treg) cells limits excessive immune responses and tissue damage, and is defined by the expression of the transcription
T cell oncogenic transformation
Given the importance of miRNAs in regulating normal T cell functions, it is not surprising that they are also associated to lymphoproliferative diseases. The first example of a miRNA involved in tumor development in human was provided by the miR-17~92 cluster (also known as oncomiR-1), which was shown to be amplified in human B cell lymphomas, and to accelerate c-myc-induced lymphomas in mice [[55], [56], [57]]. Since then, the miR-17~92 cluster was also identified as a critical regulator of T
The role of miRNAs in immune surveillance
Dysregulated miRNA expression in T cells can lead to a state of chronic inflammation and by this, indirectly favor carcinogenesis, tumor growth and metastatic spread. By contrast, a certain level of inflammation is needed to induce immune effector mechanisms, which have a negative impact on tumor growth [[73], [74], [75]]. For example, IFN-γ, which is the signature cytokine produced by TH1 cells, is a critical factor for the immune response towards tumors: it favors migration of T lymphocytes
Concluding remarks
MiRNAs play an important role in fine-tuning adaptive immune responses towards infectious agents as well as cancer, and they can also directly regulate the oncogenic transformation of T lymphocytes. While there is an increasing amount of studies that determined the expression of miRNAs in various cancer cell types, the mechanistic aspects of miRNA networks and their targets are instead still very much work in progress. A better understanding of how miRNA expression can influence normal cellular
Acknowledgments
We thank the SM lab for crucial discussions and help.
Funding
Work on this topic in the SM lab was funded by the Swiss National Science Foundation (grant number 175569); the Swiss Multiple Sclerosis Society; and the Vontobel Foundation.
Conflicts of interest
None to declare.
References (86)
- et al.
Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression
Mol. Cell.
(2016) - et al.
MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells
Immunity
(2011) - et al.
MicroRNA and cancer
Mol. Oncol
(2012) - et al.
microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
Blood
(2013) Diverse functions of miR-17-92 cluster microRNAs in T helper cells
Canc. Lett.
(2018)- et al.
MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development
Immunity
(2010) - et al.
Foxp3-Dependent MicroRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein
Immunity
(2009) - et al.
A single miRNA-mRNA interaction affects the immune response in a context- and cell-type-specific manner
Immunity
(2015) T follicular helper cell differentiation, function, and roles in disease
Immunity
(2014)- et al.
miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation
Immunity
(2014)
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses
Cell
Fine-tuning T cell receptor signaling to control T cell development
Trends Immunol.
miR-181a is an intrinsic Modulator of T Cell sensitivity and selection
Cell
MicroRNA expression profiling and DNA methylation signature for deregulated MicroRNA in cutaneous t-cell lymphoma
J. Invest. Dermatol.
A mammalian microRNA expression atlas based on small RNA library sequencing
Cell
microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1
Leuk. Res.
Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer
Adv. Canc. Res.
Macrophage activation and polarization: nomenclature and experimental guidelines
Immunity
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer
Immunity
Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity
Cell Rep.
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade
J. Biol. Chem.
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Trends Immunol.
Cellular and Molecular Immunology
Regulation of microRNA biogenesis
Nat. Rev. Mol. Cell Biol.
Drosha and Dicer: slicers cut from the same cloth
Cell Res.
Aberrant T cell differentiation in the absence of Dicer
J. Exp. Med.
The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease
J. Exp. Med.
T cell lineage choice and differentiation in the absence of the RNase III enzyme dicer
J. Exp. Med.
Oncomirs — microRNAs with a role in cancer
Nat. Rev. Canc.
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Proc. Natl. Acad. Sci. U. S. A.
MicroRNA expression profiles classify human cancers
Nature
Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1
PLoS Genet.
Posttranscriptional regulation of T helper cell fate decisions
J. Cell Biol.
Insights into regulation of the miR-17-92 cluster of miRNAs in cancer
Front. Med.
Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity
Annu. Rev. Immunol.
Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity
J. Exp. Med.
Dicer-dependent microRNA pathway safeguards regulatory T cell function
J. Exp. Med.
Requirement of bic/microRNA-155 for normal immune function
Science (80-. )
Regulation of the germinal center response by MicroRNA-155
Science (80-. )
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
Proc. Natl. Acad. Sci. U. S. A.
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis
J. Immunol.
MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression
J. Immunol.
The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling
Nat. Immunol.
Cited by (0)
- 1
These authors contributed equally to this manuscript and should be considered as joint first authors.